180 related articles for article (PubMed ID: 27185390)
21. Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.
Im I; Lee ES; Choi SJ; Lee JY; Kim YC
Bioorg Med Chem Lett; 2009 Jul; 19(13):3632-6. PubMed ID: 19464175
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate.
Wang J; Su H; Zhang T; Du J; Cui S; Yang F; Jin Q
PLoS One; 2014; 9(3):e92565. PubMed ID: 24664133
[TBL] [Abstract][Full Text] [Related]
23. Activity-Based Protein Profiling Identifies ATG4B as a Key Host Factor for Enterovirus 71 Proliferation.
Sun Y; Zheng Q; Wang Y; Pang Z; Liu J; Yin Z; Lou Z
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554687
[TBL] [Abstract][Full Text] [Related]
24. Non-covalent inhibitors of rhinovirus 3C protease.
Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
[TBL] [Abstract][Full Text] [Related]
25. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents.
Guo Z; Zhong X; Lin L; Wu S; Wang T; Chen Y; Zhai X; Wang Y; Wu H; Tong L; Han Y; Pan B; Peng Y; Si X; Zhang F; Zhao W; Zhong Z
Antiviral Res; 2014 Jan; 101():82-92. PubMed ID: 24263113
[TBL] [Abstract][Full Text] [Related]
26. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
[TBL] [Abstract][Full Text] [Related]
27. Anti-enterovirus 71 effects of chrysin and its phosphate ester.
Wang J; Zhang T; Du J; Cui S; Yang F; Jin Q
PLoS One; 2014; 9(3):e89668. PubMed ID: 24598537
[TBL] [Abstract][Full Text] [Related]
28. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of anti-EV71 agents.
Li P; Yang B; Hao F; Wang P; He H; Huang L; Zhang X; Zhang S; Peng X; Yin K; Hu J; Chen X; Gu Z; Wang L; Shen L; Hu G; Li N; Li J; Chen S; Xiao W; Wang Z; Guo Q; Chang X; Zhang L; Cai Q; Lin T
Bioorg Med Chem Lett; 2016 Jul; 26(14):3346-3350. PubMed ID: 27234148
[TBL] [Abstract][Full Text] [Related]
30. Structural analysis of foot-and-mouth disease virus 3C protease: a viable target for antiviral drugs?
Curry S; Roqué-Rosell N; Sweeney TR; Zunszain PA; Leatherbarrow RJ
Biochem Soc Trans; 2007 Jun; 35(Pt 3):594-8. PubMed ID: 17511659
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
[TBL] [Abstract][Full Text] [Related]
32. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease.
Liu M; Xu B; Ma Y; Shang L; Ye S; Wang Y
Antiviral Res; 2021 Aug; 192():105102. PubMed ID: 34082057
[TBL] [Abstract][Full Text] [Related]
33. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2.
Dai W; Jochmans D; Xie H; Yang H; Li J; Su H; Chang D; Wang J; Peng J; Zhu L; Nian Y; Hilgenfeld R; Jiang H; Chen K; Zhang L; Xu Y; Neyts J; Liu H
J Med Chem; 2022 Feb; 65(4):2794-2808. PubMed ID: 33872498
[TBL] [Abstract][Full Text] [Related]
35. Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells.
Zhang Y; Ke X; Zheng C; Liu Y; Xie L; Zheng Z; Wang H
Sci Rep; 2017 Sep; 7(1):10385. PubMed ID: 28871120
[TBL] [Abstract][Full Text] [Related]
36. 4-Iminooxazolidin-2-One as a Bioisostere of Cyanohydrin Suppresses EV71 Proliferation by Targeting 3C
Xu B; Liu M; Ma S; Ma Y; Liu S; Shang L; Zhu C; Ye S; Wang Y
Microbiol Spectr; 2021 Dec; 9(3):e0102521. PubMed ID: 34787443
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: A molecular dynamics study.
Jetsadawisut W; Nutho B; Meeprasert A; Rungrotmongkol T; Kungwan N; Wolschann P; Hannongbua S
Biophys Chem; 2016 Dec; 219():9-16. PubMed ID: 27668727
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.
Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Reich SH; Marakovits JT; Prins TJ; Zhou R; Tikhe J; Littlefield ES; Bleckman TM; Wallace MB; Little TL; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; DeLisle DM; Worland ST
J Med Chem; 1998 Jul; 41(15):2819-34. PubMed ID: 9667971
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Johnson TO; Brown EL; Maldonado FC; Fuhrman SA; Zalman LS; Patick AK; Matthews DA; Hou X; Meador JW; Ferre RA; Worland ST
Bioorg Med Chem Lett; 2002 Mar; 12(5):733-8. PubMed ID: 11858991
[TBL] [Abstract][Full Text] [Related]
40. The Function and Mechanism of Enterovirus 71 (EV71) 3C Protease.
Wen W; Qi Z; Wang J
Curr Microbiol; 2020 Sep; 77(9):1968-1975. PubMed ID: 32556480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
